18 min listen
New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302
New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302
ratings:
Length:
11 minutes
Released:
Nov 14, 2022
Format:
Podcast episode
Description
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
Released:
Nov 14, 2022
Format:
Podcast episode
Titles in the series (100)
Breast Cancer and the Harms of Overdiagnosis - Frankly Speaking EP6: In this podcast episode, we consider the premise of overdiagnosis and how it applies to women being screened for breast cancer and highlight ways to mitigate the risks of overdiagnosis of breast cancer. by Frankly Speaking About Family Medicine